(Q38939434)

7 September 2017

title

Rifampicin loaded mannosylated cationic nanostructured lipid carriers for alveolar macrophage-specific delivery (English)

1 reference

7 September 2017

0 references

1 reference

Xu Song

1

1 reference

7 September 2017

Qing Lin

2

1 reference

7 September 2017

Ling Guo

3

1 reference

7 September 2017

Yao Fu

4

1 reference

7 September 2017

Jianfeng Han

5

1 reference

7 September 2017

Huan Ke

6

1 reference

7 September 2017

Xun Sun

7

1 reference

7 September 2017

Tao Gong

8

1 reference

7 September 2017

Zhirong Zhang

9

1 reference

7 September 2017

publication date

19 November 2014

1 reference

7 September 2017

published in

Pharmaceutical Research

1 reference

7 September 2017

volume

32

1 reference

7 September 2017

issue

5

1 reference

7 September 2017

page(s)

1741-1751

1 reference

Infectious Diseases: Considerations for the 21st Century

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Use of liposome preparation to treat mycobacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Innate immune responses to M. tuberculosis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Persistence of Mycobacterium tuberculosis in macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Efficient targeting to alveolar macrophages by intratracheal administration of mannosylated liposomes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

A retrospective, comparative evaluation of dysglycemias in hospitalized patients receiving gatifloxacin, levofloxacin, ciprofloxacin, or ceftriaxone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Sizing nanomatter in biological fluids by fluorescence single particle tracking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Characteristics and biodistribution of cationic liposomes and their DNA complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Cationic bovine serum albumin based self-assembled nanoparticles as siRNA delivery vector for treating lung metastatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Threshold size for optimal passive pulmonary targeting and retention of rigid microparticles in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Biodistribution and renal clearance of biocompatible lung targeted poly(ethylene glycol) (PEG) nanogel aggregates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Cellular targeting and trafficking of drug delivery systems for the prevention and treatment of MTb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Delivery systems to increase the selectivity of antibiotics in phagocytic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Therapeutic potential of nanoparticulate systems for macrophage targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Dendritic cell targeted liposomes-protamine-DNA complexes mediated by synthetic mannosylated cholesterol as a potential carrier for DNA vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Mannosylated lipid nano-emulsions loaded with lycorine-oleic acid ionic complex for tumor cell-specific delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Enhanced DNA vaccine potency by mannosylated lipoplex after intraperitoneal administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Doxorubicin-conjugated quantum dots to target alveolar macrophages and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Formulation and in vitro characterization of inhalable polyvinyl alcohol-free rifampicin-loaded PLGA microspheres prepared with sucrose palmitate as stabilizer: efficiency for ex vivo alveolar macrophage targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Optimum conditions for efficient phagocytosis of rifampicin-loaded PLGA microspheres by alveolar macrophages.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Nanostructured lipid matrices for improved microencapsulation of drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Development of ionic-complex-based nanostructured lipid carriers to improve the pharmacokinetic profiles of breviscapine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Adsorption kinetics of plasma proteins on solid lipid nanoparticles for drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Monitoring the disassembly of siRNA polyplexes in serum is crucial for predicting their biological efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Liposome based systems for systemic siRNA delivery: stability in blood sets the requirements for optimal carrier design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1572-3

Design of liposomes to improve delivery of macrophage-augmenting agents to alveolar macrophages

21 January 2018

1 reference

12 December 2020

Influence of rifampicin on the pharmacokinetics of salvianolic acid B may involve inhibition of organic anion transporting polypeptide (Oatp) mediated influx

1 reference

12 December 2020

Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC): their benefits as colloidal drug carrier systems

1 reference

12 December 2020

Final in-line filtration: removal of contaminants from IV fluids and drugs

1 reference

12 December 2020

Terminalia chebula (fruit) prevents liver toxicity caused by sub-chronic administration of rifampicin, isoniazid and pyrazinamide in combination

1 reference

12 December 2020

The targeting of drugs parenterally by use of microspheres

1 reference

12 December 2020

Studies on the relationship between the electrophoretic properties of colloids and their blood clearance and organ distribution in the rat

1 reference

12 December 2020

Lung surfactant phospholipids inhibit the uptake of respirable microspheres by the alveolar macrophage NR8383

1 reference

12 December 2020

Interaction of high molecular weight kininogen, factor XII, and fibrinogen in plasma at interfaces

1 reference

12 December 2020

Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces

1 reference

12 December 2020

Systemic delivery of microRNA-34a for cancer stem cell therapy

1 reference

12 December 2020

Automated determination of rifampicin in plasma samples by in-tube solid-phase microextraction coupled with liquid chromatography

1 reference

12 December 2020

10.1007/S11095-014-1572-3

Identifiers

DOI

1 reference

7 September 2017

1 reference